...
首页> 外文期刊>Frontiers in Cell and Developmental Biology >Activation of TWIST Transcription by Chromatin Remodeling Protein BRG1 Contributes to Liver Fibrosis in Mice
【24h】

Activation of TWIST Transcription by Chromatin Remodeling Protein BRG1 Contributes to Liver Fibrosis in Mice

机译:染色质重塑蛋白BRG1的扭曲转录激活有助于小鼠肝纤维化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Liver fibrosis is complex pathophysiological process to which many different cell types contribute. Endothelial cells play versatile roles in the regulation of liver fibrosis. The underlying epigenetic mechanism is not fully appreciated. In the present study, we investigated the role of BRG1, a chromatin remodeling protein, in the modulation of endothelial cells in response to pro-fibrogenic stimuli in vitro and liver fibrosis in mice. We report that depletion of BRG1 by siRNA abrogated TGF-b or hypoxia induced down-regulation of endothelial marker genes and up-regulation of mesenchymal marker genes in cultured endothelial cells. Importantly, endothelial-specific BRG1 deletion attenuated CCl4 induced liver fibrosis. BRG1 knockdown in vitro or BRG1 knockout in vivo was accompanied by the down-regulation of TWIST, a key regulator of endothelial phenotype. Mechanistically, BRG1 interacted with and was recruited to the TWIST promoter by HIF-1a to activate TWIST transcription. BRG1 silencing rendered a more repressive chromatin structure surrounding the TWIST promoter likely contributing to TWIST down-regulation. Inhibition of HIF-1a activity dampened liver fibrosis in mice. Similarly, pharmaceutical inhibition of TWIST alleviated liver fibrosis in mice. In conclusion, our data suggest that epigenetic activation of TWIST by BRG1 contributes to the modulation of endothelial phenotype and liver fibrosis. Therefore, targeting the HIF1a-BRG1-TWIST axis may yield novel therapeutic solutions to treat liver fibrosis.
机译:肝纤维化是复杂的病理生理过程,许多不同的细胞类型有贡献。内皮细胞在肝纤维化调节中发挥多功能作用。潜在的表观遗传机制并不完全赞赏。在本研究中,我们研究了BRG1,染色质重塑蛋白在内皮细胞调节中的作用,响应于小鼠体外和肝纤维化的体外纤维化刺激。我们认为SiRNA废除TGF-B或缺氧的耗尽诱导培养内皮细胞中内皮标记基因的下调和上调间充质标志物基因的下调。重要的是,内皮特异性BRG1缺失减毒CCL4诱导的肝纤维化。 BRG1在体外敲低或体内BRG1敲除伴随着扭曲的下调,内皮表型的关键调节器。机械地,BRG1与HIF-1A募集到捻启动子以激活捻转录。 BRG1沉默使围绕扭曲启动子的更加抑制染色质结构,可能有助于扭曲下调。 HIF-1A活性抑制小鼠肝纤维化的抑制作用。类似地,药物抑制小鼠扭曲缓解肝纤维化。总之,我们的数据表明BRG1扭曲的表观遗传活化有助于内皮表型和肝纤维化的调节。因此,靶向HIF1A-BRG1-扭转轴可以产生新的治疗溶液来治疗肝纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号